Press Releases
Syntegon delivers strong growth and EBITDA improvements in first half of 2025
Successful growth strategy delivers sales growth in H1 of +11% versus prior year to €824m
Strong growth momentum in the Pharma segment
EBITDA up +41% to €127m, with margin expanding 300 bps to 15.5%.; all business units contributing
...
Press Releases
Reliable Labeling at Cryogenic Temperatures
In the pharmaceutical cold chain, labels must perform from +8 °C down to –196 °C in liquid nitrogen. At such extremes, conventional adhesives lose tack and ice films hinder adhesion.
Melsungen, August 26, 2025
Biopharmaceuticals such as vaccines and advanced therapy...
Business & Industry
Er-Kim Announces Exclusive Agreement with CNX Therapeutics to Distribute Oncology Products Across CEE and Turkey
Partnership will broaden portfolio distribution of oncology products to cancer patients in the specified regions
Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced a distribution agreement with CNX Therapeutics to supply selected oncology products across Central...
Press Releases
Record international attendance at CPHI & PMEC China 2025 as China in-licensing deals and international partnering increase
China’s biotech sector is now a key driver of innovation across global pipelines, as CPHI Shenzhen prepares for largest ever influx of foreign dealmakers
Sino-international trade is accelerating as CPHI & PMEC China (June 24–26, 2025) reported a record-breaking international...
Packaging & Labelling
Autopack to host biggest packaging machinery stand at PPMA Total 2025
Leading independent integrator of packaging lines Autopack will showcase a range of cutting-edge automated equipment at PPMA Total 2025, which takes place at Birmingham’s NEC from 23-25 September. The Hereford-based business will take its largest individual stand to date in what...
Press Releases
Friends of Cancer Research and MMS Collaborate to Develop Decision Frameworks for Interim Overall Survival Data in Oncology Trials
MMS, a global, data-focused clinical research organization (CRO), announced today that it has been chosen by Friends of Cancer Research (Friends), a leading nonprofit dedicated to accelerating innovation in cancer research, to support the development of practical decision frameworks...
Clinical Trials
PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery
PADCEV plus KEYTRUDA is the first and only regimen to improve survival when used before and after standard of care (surgical cystectomy) in cisplatin-ineligible patients with muscle-invasive bladder cancer
Results will be discussed with global health authorities for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















